A Clinical Trial To Assess The Effectiveness Of Virechana(Purgation) Dadrughna Kashaya(Liquid Orally) And Vidangadi lepa(External Application) In Dadru Kushta With Special Reference To Tinea(Fungal) Infection

An Open Labelled Exploratory Clinical Trial To Assess The Effectiveness Of Virechana, Dadrughna Kashaya And Vidangadilepa In Dadru Kushta With Special Reference To Tinea Infection

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020295

Enrollment

Registered

2019-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: AJAMODADI CHURNA PATOLADYA GHRITA CHAKRAMARDA TAILA TRIVRUT LEHYA DADRUGHNA KASHAYA VIDANGADI LEPA: AJAMODADI CHURNA 5GM TWICE A DAY FOR AMAPACHANA PATOLADYA GHRITA 100ML FOR SNEHAPANA

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with classical symptoms of Dadru as Twak Kandu,Raga, Pidaka and Mandala Subjects of both gender, irrespective of socio â??economic status. Subjects belonging to age group between 20- 60 years of age Subjects fit for Snehapana and Virechana

Exclusion criteria

Exclusion criteria: Subjects suffering from any chronic illness and other metabolic disorders Subjects suffering from HIV/ HBsAg/VDRL/STDs will be excluded Pregnant and Lactating women Other skin manifestations.

Design outcomes

Primary

Measure	Time frame
Kandu Raga Pidaka Number of Mandala Size of Mandala Timepoint: At The End of 60 days of trial	—

Secondary

Measure	Time frame
AEC TC DC ESR SKIN SCRAPING TEST KOH MOUNT (if necessary) Timepoint: At The End of 60 Days Of Trial	—

Countries

India

Contacts

Public ContactDr Asha A Bhat

Ayurveda Mahavidyalaya And Hospital

drprashanthayurved@gmail.com9448135575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026